Kendall D Carey

age ~60

from Yardley, PA

Get Report

Also known as:

Kendall D Curry
Carey D Kendall

Phone and address:: 23 Edgewood Rd, Yardley, PA 19067

Connected to:

Kendall Carey Phones & Addresses

23 Edgewood Rd, Morrisville, PA 19067
Yardley, PA
Bensalem, PA
South San Francisco, CA
San Mateo, CA
Germantown, MD
Seattle, WA
Bothell, WA
San Francisco, CA
Portland, OR

Work

Company:

Celgene
Jul 2017
Position:

Director

Education

Degree:

Doctorates, Doctor of Philosophy
School / High School:

Oregon Health & Science University
1998 to 2002
Specialities:

Molecular Biology, Philosophy

Skills

Analytical Method Development and Valida... • Cell Based Assays • Cell Biology • Molecular and Cellular Biology • Immunoassays • Impurities • Cell Lines • Cell Signaling • Recombinant Dna • Cell Line Engineering • Protein Characterization • Protein Purification • Life Sciences • Virology • Automation • Neuroscience • Molecular Oncology • Target Validation • Targeted Drug Delivery • Protein Expression • Protein Engineering

Ranks

Certificate:

Prevent Workplace Harassment

Industries

Biotechnology

Resumes

Analytical Sciences And Quality Control

view source

Location:

950 Wind River Ln, Gaithersburg, MD 20878

Industry:

Biotechnology

Work:

Celgene
Director
Bristol-Myers Squibb
Group Leader
Genentech Sep 2012 - Jan 2015
Qc Senior Scientist
Medimmune Jan 1, 2009 - Sep 2012
Scientist Ii at Medimmune
Amgen 2006 - 2009
Scientist

Education:

Oregon Health & Science University 1998 - 2002
Doctorates, Doctor of Philosophy, Molecular Biology, Philosophy The Ohio State University 1984 - 1989
Bachelors, Bachelor of Science, Molecular Biology, Biochemistry

Skills:

Analytical Method Development and Validation For Biotherapeutics
Cell Based Assays
Cell Biology
Molecular and Cellular Biology
Immunoassays
Impurities
Cell Lines
Cell Signaling
Recombinant Dna
Cell Line Engineering
Protein Characterization
Protein Purification
Life Sciences
Virology
Automation
Neuroscience
Molecular Oncology
Target Validation
Targeted Drug Delivery
Protein Expression
Protein Engineering

Certifications:

Prevent Workplace Harassment

Us Patents

Inhibiting Her2 Shedding With Matrix Metalloprotease Antagonists
view source
US Patent:

20060177448, Aug 10, 2006
Filed:

Feb 9, 2006
Appl. No.:

11/351811
Inventors:

Kendall Carey - South San Francisco CA, US
Ralph Schwall - Pacifica CA, US
Mark Sliwkowski - San Carlos CA, US
Gail Schwall - Pacifica CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

G01N 33/574
A61K 39/395
US Classification:

424146100, 435007230
Abstract:

The present application describes using antagonists of matrix metalloproteases (MMPs), especially of MMP-15, for inhibiting HER2 shedding.

Cell-Based Assay For Detecting Antl-Cd3 Homodimers
view source
US Patent:

20200378987, Dec 3, 2020
Filed:

May 14, 2020
Appl. No.:

16/874550
Inventors:

- South San Francisco CA, US
Kendall CAREY - South San Francisco CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

G01N 33/68
C07K 16/28
G01N 33/50
Abstract:

The present invention provides a cell-based assay for identifying and/or quantifying anti-CD3 homodimers in a composition comprising a T cell-dependent Bispecific antibody (TDB). In some aspects, the invention T cells comprising a T cell activation responsive reporter are contacted with the TDB to detect the presence of anti-CD3 homodimers. Compositions of reporter T cells and kits are also contemplated.

Methods For Assaying T-Cell Dependent Bispecific Antibodies
view source
US Patent:

20200182882, Jun 11, 2020
Filed:

Jan 25, 2017
Appl. No.:

16/072486
Inventors:

- South San Francisco CA, US
Guoying JIANG - South San Francisco CA, US
Pin Yee WONG - South San Francisco CA, US
Kendall CAREY - South San Francisco CA, US
International Classification:

G01N 33/68
C12Q 1/66
G01N 33/50
C07K 16/28
Abstract:

The present invention provides a cell-based assay for measuring T cell activation mediated by a T cell -dependent bispecific antibody (TDB). In some aspects, the assay is useful for detecting a TDB in a composition, quantitating the amount of TDB in a composition, determining the potency and/or specificity of a TDB, or determining if a population of cells expresses a target antigen. Compositions and kits are also contemplated.

Cell-Based Assay For Detecting Anti-Cd3 Homodimers
view source
US Patent:

20180267055, Sep 20, 2018
Filed:

Nov 28, 2017
Appl. No.:

15/824992
Inventors:

- South San Francisco CA, US
Kendall CAREY - South San Francisco CA, US
Assignee:

Genentech, Inc. - South San Francisco CA
International Classification:

G01N 33/68
C07K 16/28
Abstract:

The present invention provides a cell-based assay for identifying and/or quantifying anti-CD3 homodimers in a composition comprising a T cell-dependent Bispecific antibody (TDB). In some aspects, the invention T cells comprising a T cell activation responsive reporter are contacted with the TDB to detect the presence of anti-CD3 homodimers. Compositions of reporter T cells and kits are also contemplated.